Screener
Sana Biotechnology SANA Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Sana Biotechnology in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Sana Biotechnology’s 10-Q, filed May 11, 2026. Open the filing →
- Filed
- May 11, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-216769
FAQ
- What is Sana Biotechnology's shares (diluted)?
- Sana Biotechnology (SANA) reported shares (diluted) of 276.9M in Q1 2026.
- How has Sana Biotechnology's shares (diluted) changed year-over-year?
- Sana Biotechnology's shares (diluted) increased by 16.5% year-over-year, from 237.6M to 276.9M.
- What is the long-term trend for Sana Biotechnology's shares (diluted)?
- Over 4 years (2021 to 2025), Sana Biotechnology's shares (diluted) has grown at a 10.7% compound annual growth rate (CAGR), from 657.9M to 989.7M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Sana Biotechnology's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude